Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 15;148(4):981-987.
doi: 10.1002/ijc.33327. Epub 2020 Oct 13.

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder

Affiliations

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder

Thomas van Doeveren et al. Int J Cancer. .

Abstract

The risk of developing urothelial carcinoma of the bladder (UCB) in patients treated by radical nephroureterectomy (RNU) for an upper urinary tract urothelial carcinoma (UTUC) is 22% to 47% in the 2 years after surgery. Subject of debate remains whether UTUC and the subsequent UCB are clonally related or represent separate origins. To investigate the clonal relationship between both entities, we performed targeted DNA sequencing of a panel of 41 genes on matched normal and tumor tissue of 15 primary UTUC patients treated by RNU who later developed 19 UCBs. Based on the detected tumor-specific DNA aberrations, the paired UTUC and UCB(s) of 11 patients (73.3%) showed a clonal relation, whereas in four patients the molecular results did not indicate a clear clonal relationship. Our results support the hypothesis that UCBs following a primary surgically resected UTUC are predominantly clonally derived recurrences and not separate entities.

Keywords: bladder carcinoma; clonality; upper urinary tract carcinoma; urothelial carcinoma.

PubMed Disclaimer

Conflict of interest statement

J. L. Boormans reports on consultancy work for MSD, Janssen, Ambu, Health care and Ismar, during the conduct of the study; and received a research grant from Decipher Biosciences. All other authors report no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Assessment of the clonal relation of 15 primary UTUC and 19 subsequent UCBs based on (non)shared tumor‐specific genomic alterations between both entities detected by next‐generation sequencing. Additional transcriptomic profiling based on mRNAseq data is included for patients X, XI, XII and XIV (NU, normal ureteric tissue; UCB, urothelial carcinoma of the bladder; UTUC, upper urinary tract urothelial carcinoma) [Color figure can be viewed at wileyonlinelibrary.com]

Similar articles

Cited by

References

    1. Roupret M, Babjuk M, Burger M, et al. European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol. 2020. - PubMed
    1. Harris AL, Neal DE. Bladder cancer—field versus clonal origin. N Engl J Med. 1992;326:759‐761. - PubMed
    1. Habuchi T. Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications. Int J Urol. 2005;12:709‐716. - PubMed
    1. van Doeveren T, van de Werken HJG, van Riet J, et al. Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: are they clonally related? A systematic review. Urol Oncol. 2020;38(6):590‐598. - PubMed
    1. Pruis MA, Geurts‐Giele WRR, von der TJH, et al. Highly accurate DNA‐based detection and treatment results of MET exon 14 skipping mutations in lung cancer. Lung Cancer. 2020;140:46‐54. - PubMed

Publication types

MeSH terms